Keyphrases
Epigenetics
100%
Reinvigoration
100%
Immune Checkpoint Blockade
100%
Exhausted T Cells
100%
Checkpoint Blockade
100%
Immunotherapy Response
100%
Dysfunctional T Cells
100%
T Cells
40%
Cancer Cells
20%
T Cell Receptor
20%
Immune Cells
20%
Overcoming Resistance
20%
Tumor Cells
20%
Tumor Progression
20%
In Cancer
20%
Cancer Types
20%
Molecular Study
20%
Clinical Efficacy
20%
T Cell Subpopulations
20%
Epigenetic Modifiers
20%
Epigenetic Modification
20%
Epigenetic Landscape
20%
Immunosuppression
20%
Programmed Death-ligand 1 (PD-L1)
20%
Varying Response
20%
Checkpoint Molecules
20%
Cancer Therapy
20%
Durable Response
20%
T Cell Exhaustion
20%
T Cell Immunotherapy
20%
Cell Tolerance
20%
T Cell Depletion
20%
T Cell Heterogeneity
20%
T-cell Phenotype
20%
Immunotherapy Resistance
20%
Resistance to Immunotherapy
20%
Immunology and Microbiology
T Cell
100%
Immunotherapy
100%
Immune Checkpoint Blockade
100%
T Cell Receptor
12%
Immunocompetent Cell
12%
Cancer Cell
12%
Tumor Cell
12%
Cell Population
12%
Immunosuppression
12%
Cell Heterogeneity
12%
Programmed Death 1 Ligand 1
12%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Epigenetics
100%
Immune Checkpoints
100%
Cancer Cell
12%
Immunocompetent Cell
12%
Tumor Progression
12%
T Cell Receptor
12%
Cell Heterogeneity
12%